Schedule A to the Statement is hereby deleted in its entirety and replaced with Schedule A attached to this Amendment No. 9.

Item 3 is hereby amended and supplemented as follows: On June 30, 2026, the Issuer issued an aggregate of 13,619,377 shares of Common Stock to OC III LFE in accordance with OC III LFE's partial exercise of certain warrants (the "Partial Exercises"). In particular, OC III LFE partially exercised (a) a warrant, which was originally issued pursuant to the terms of the warrant acquisition agreement, dated as of October 13, 2020 (the "2020 Warrant"), to purchase a number of shares of Common Stock equal to 22.99% of the Common Stock Deemed Outstanding (as defined in the 2020 Warrant), (b) a warrant, which was originally issued pursuant to the terms of the warrant acquisition agreement, dated as of December 30, 2021 (the "2021 Warrant"), to purchase a number of shares of Common Stock equal to 4.99% of the Common Stock Deemed Outstanding (as defined in the 2021 Warrant), and (c) a warrant, which was originally issued pursuant to the terms of the warrant acquisition agreement, dated as of April 4, 2022 (the "2022 Warrant"), to purchase a number of shares of Common Stock equal to 4.99% of the Common Stock Deemed Outstanding (as defined in the 2022 Warrant). Each such share of Common Stock was purchased at a price of $0.01 pursuant to the respective net exercise provisions governing the warrants.

Item 6 is hereby amended and supplemented as follows: The disclosure set forth in Item 3 of this Amendment No. 9 is incorporated herein by reference. On June 30, 2026, as a result of the Partial Exercises of the 2020 Warrant, the 2021 Warrant and the 2022 Warrant, the Issuer issued replacement warrants (in the case of the 2020 Warrant, the "Replacement 2020 Warrant"; in the case of the 2021 Warrant, the "Replacement 2021 Warrant"; and in the case of the 2022 Warrant, the "Replacement 2022 Warrant") entitling OC III LFE or its assigns to subscribe for and purchase from the Issuer the remaining unpurchased shares under the respective original warrants. The foregoing descriptions of the Replacement 2020 Warrant, the Replacement 2021 Warrant and the Replacement 2022 Warrant are qualified in their entireties by reference to the full texts of such warrants, the forms of which are included as Exhibits 99.1, 99.2 and 99.3, respectively, hereto and are incorporated by reference herein. On December 31, 2024, the Issuer redeemed all outstanding shares of Preferred Stock from the Purchaser and, thereafter, the Preferred Stock ceased to be outstanding. Except as set forth herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any person with respect to any securities of the Issuer, including any class of the Issuer's securities used as a reference security, in connection with any of the following: call options, put options, security-based swaps or any other derivative securities, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

Exhibit 99.1: Form of Replacement 2020 Warrant Exhibit 99.2: Form of Replacement 2021 Warrant Exhibit 99.3: Form of Replacement 2022 Warrant